The settlement, announced on Wednesday, resolves 93% of all Zantac cases in state courts against GlaxoSmithKline.

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...

UK-based pharmaceutical giant GSK, or GlaxoSmithKline, has announced that it has agreed to settle nearly 80,000 state-level ...

Pharmaceutical giant GlaxoSmithKline (GSK) has agreed to pay up to $2.2 billion to settle most of lawsuits filed in U.S.

GSK has always refuted claims that its discontinued heartburn drug had cancer-causing risks, arguing that expert testimonies ...

The announcement sparked speculation that a number of health companies would be interested in buying the Pfizer business. These include GlaxoSmithKline, though it is already looking to buy ...

There has also been speculation that Pfizer may switch its attention to AZ's UK rival GlaxoSmithKline (GSK), although analysts have suggested the latter is not such a good fit. Pfizer would like ...

San Antonio attorney Mikal Watts is among a group of lawyers that negotiated a settlement of as much as $2.2 billion to resolve claims by about 80,000 people who allege a discontinued version of the ...

MM Hoeper has received speaking fees, grant/research support and is a consultant for Encysive Pharmaceuticals, Actelion Pharmaceuticals, GlaxoSmithKline, Pfizer and Bayer-Schering Pharma.

RSV vaccine sales from GSK and Pfizer have dropped significantly following revised CDC guidelines, narrowing the eligible age ...